Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page footer.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this is a minor update with no visible changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded Andover Eye Associates as a collaborator/sponsor and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check44 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Minor wording/capitalization updates to FEAR Act data references and removal of older QC/version references (e.g., 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4').SummaryDifference0.2%

- Check59 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded a Locations section listing study sites by state (CA, CO, FL, KS, MA, MI, MO, NY, NC, ND, PA, TN, TX, WA) and updated the page revision from v3.3.2 to v3.3.3. The previous state-specific location sections were removed.SummaryDifference1%

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.